In Situ Regulation of Macrophage Polarization to Enhance Osseointegration Under Diabetic Conditions Using Injectable Silk/Sitagliptin Gel Scaffolds

Geng Xiang,Keyin Liu,Tianji Wang,Xiaofan Hu,Jing Wang,Zhiheng Gao,Wei Lei,Yafei Feng,Tiger H. Tao

DOI: https://doi.org/10.1002/advs.202002328

IF: 15.1

2020-12-16

Advanced Science

Abstract:<p>As a chronic inflammatory disease, diabetes mellitus creates a proinflammatory microenvironment around implants, resulting in a high rate of implant loosening or failure in osteological therapies. In this study, macroporous silk gel scaffolds are injected to the bone‐implant interface for in situ release of sitagliptin that can regulate macrophage response to create a prohealing microenvironment in diabetes mellitus disease. Notably, it is discovered for the first time that sitagliptin‐induced macrophage polarization to the M2 phenotype and alleviated the impaired behaviors of osteoblasts on titanium (Ti) implants under diabetic conditions in a dose‐dependent manner. The silk gel scaffolds loaded with sitagliptin elicite a stronger recruitment of M2 macrophages to the sites of Ti implants and a significant promotion of osteointegration, as compared to oral sitagliptin administration. The results suggest that injectable silk/sitagliptin gel scaffolds can be utilized to modulate the immune responses at the bone‐implant interface, thus enhancing bone regeneration requires for successful implantation of orthopedic and dental devices in diabetic patients.</p>

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry

What problem does this paper attempt to address?

This paper attempts to solve the problem of osseointegration failure of titanium alloy implants under diabetic conditions. Specifically, diabetes creates a pro - inflammatory microenvironment, which leads to a reduced osseointegration rate around the implant, thereby increasing the risk of implant loosening or failure. This article proposes a new technique, that is, using an injectable silk fibroin/sitagliptin gel scaffold to locally and continuously release sitagliptin at the contact surface between the implant and the bone, in order to regulate the polarization of macrophages and promote the transformation from pro - inflammatory M1 macrophages to pro - healing M2 macrophages, thereby improving osseointegration under diabetic conditions.

Through this method, researchers hope to improve the bone regeneration ability in diabetic patients and reduce the risk of implant failure caused by hyperglycemia, thus providing a new strategy for the successful implantation of orthopedic and dental devices. This technique can not only improve the treatment effect of diabetic patients, but also may provide solutions to osseointegration problems in other chronic inflammatory diseases.